We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

152 hedge funds and large institutions have $315M invested in NEVRO CORP. in 2024 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 59 increasing their positions, 45 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 45

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 31

1% less funds holding

Funds holding: 153152 (-1)

42% less capital invested

Capital invested by funds: $539M → $315M (-$224M)

97% less call options, than puts

Call options by funds: $426K | Put options by funds: $13M

Holders
152
Holders Change
-1
Holders Change %
-0.65%
% of All Funds
2.2%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
31
Increased
59
Reduced
45
Closed
31
Calls
$426K
Puts
$13M
Net Calls
-$12.5M
Net Calls Change
+$430K
Name Holding Trade Value Shares
Change
Change in
Stake
TCM
51
TD Capital Management
Tennessee
$713K
Walleye Capital
52
Walleye Capital
New York
$636K +$439K +41,139 +119%
Envestnet Asset Management
53
Envestnet Asset Management
Illinois
$629K -$158K -14,850 -17%
Deutsche Bank
54
Deutsche Bank
Germany
$628K -$497K -46,629 -38%
Balyasny Asset Management
55
Balyasny Asset Management
Illinois
$583K +$167K +15,630 +29%
NRD
56
Nebula Research & Development
New York
$568K +$536K +50,253 +293%
WWS
57
Wellington Wealth Strategies
Indiana
$539K +$757 +71 New
Swiss National Bank
58
Swiss National Bank
Switzerland
$513K -$37.3K -3,500 -5%
William Blair & Company
59
William Blair & Company
Illinois
$500K +$77.3K +7,250 +14%
RhumbLine Advisers
60
RhumbLine Advisers
Massachusetts
$497K +$30.2K +2,836 +5%
AQR Capital Management
61
AQR Capital Management
Connecticut
$470K +$595K +55,840 New
T. Rowe Price Associates
62
T. Rowe Price Associates
Maryland
$469K +$113K +10,639 +24%
HSBC Holdings
63
HSBC Holdings
United Kingdom
$459K +$104K +9,793 +21%
Invesco
64
Invesco
Georgia
$449K -$10.2K -953 -2%
AllianceBernstein
65
AllianceBernstein
Tennessee
$445K +$172K +16,170 +44%
M&T Bank
66
M&T Bank
New York
$432K +$111K +10,376 +25%
BNP Paribas Financial Markets
67
BNP Paribas Financial Markets
France
$419K -$18.9K -1,776 -3%
JF
68
Jump Financial
Illinois
$385K -$386K -36,211 -44%
TI
69
Tidal Investments
Wisconsin
$372K +$471K +44,190 New
Russell Investments Group
70
Russell Investments Group
United Kingdom
$370K +$455K +42,651 +3,396%
CC
71
Centiva Capital
New York
$366K +$325K +30,490 +234%
DTL
72
Dynamic Technology Lab
Singapore
$273K +$346K +32,421 New
Truist Financial
73
Truist Financial
North Carolina
$270K -$14.7K -1,379 -4%
OAM
74
Oppenheimer Asset Management
New York
$261K +$3.33K +312 +1%
California State Teachers Retirement System (CalSTRS)
75
California State Teachers Retirement System (CalSTRS)
California
$257K -$25.8K -2,422 -7%

NVRO Hedge Fund Activity: Q2 2024 in Review

152 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q2 2024, worth a combined $315M — down 42% from $539M a quarter earlier.

Fund positioning in NVRO was balanced in Q2 2024: 31 funds opened new positions, 31 closed out, 59 added to existing stakes and 45 trimmed.

The largest buyer was ArrowMark Colorado Holdings, adding an estimated $15.9M. The largest seller was Principal Financial Group, exiting entirely with an estimated $10.3M sold.

  • 152 institutional investors held NEVRO CORP. (NVRO) as of Q2 2024, down from 153 in Q1 2024.
  • Funds reported $315M of NEVRO CORP. stock for Q2 2024, down 42% quarter-over-quarter.
  • 31 funds opened new NEVRO CORP. positions in Q2 2024 and 31 closed out, a net change of 0 holders.
  • The largest NEVRO CORP. buyer in Q2 2024 was ArrowMark Colorado Holdings, an estimated $15.9M added.
  • The largest NEVRO CORP. seller in Q2 2024 was Principal Financial Group, an estimated $10.3M sold.

Based on aggregated 13F filings for Q2 2024.